Neoadjuvant chemo-hormonal therapy before robot-assisted radical prostatectomy resulted in favorable biochemical progression-free survival rates in patients with very high-risk prostate cancer. This result suggests that this therapeutic approach has potential for becoming a new standard of care.
Building similarity graph...
Analyzing shared references across papers
Loading...
Yuri Koyama
Tottori University
Shuichi Morizane
Emika Moriyasu
Tottori University
Tottori University
Building similarity graph...
Analyzing shared references across papers
Loading...
Koyama et al. (Sun,) studied this question.
synapsesocial.com/papers/699f956d1bc9fecf3dab3385 — DOI: https://doi.org/10.1111/iju.70387